Citations

Mayo Clinic

Clear

88156 citation(s) found for "NA".

Single-cell transcriptomic atlas of frontoinsular cortex reveals molecular correlates of selective neuronal vulnerability in FTD
Breevoort, Arnar , Ivanov, Dimitar, Horan-Portelance, Liam , Nana, Alissa , Vatsavayai, Sarat, Miravet, Alex Tudoras, Wallace, Jenelle L., Ding, Jingwen W., Pereira, Felipe L., Fernhoff, Kristen, Gorno-Tempini, Maria Luisa, Spina, Salvatore, Yokoyama, Jennifer S., Rosen, Howard J., Grinberg, Lea T., Jacobs, Frank M. J., Miller, Bruce L., Seeley, William , Pollen, Alex A , Nana, Alissa L , Breevoort, Arnar , Horan-Portelance, Liam , Vatsavayai, Sarat C. , Tudoras, Àlex, Wallace, Jenelle L. , Ding, Jingwen W, Pereira, Felipe L., Fernhoff, Kristen, Gorno‐Tempini, Maria Luisa , Spina, Salvatore , Yokoyama, Jennifer S. , Rosen, Howard J. , Grinberg, Lea T. , Jacobs, Frank M. J. , Seeley, William W.

No container title available | July 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.07.13.738307 | PMID 42523377 Get It

Abstract Frontotemporal dementia (FTD) is characterized by selective neuronal vulnerability, yet the features that predispose specific neuron types to degeneration remain unclear. We performed single-nucleus RNA sequencing of frontoinsular cortex, a region affected early in behavioral variant FTD, across individuals with C9orf72 -associated and sporadic FTD-MND spectrum disease. By enriching for large projection neurons, we resolved molecular subtypes of layer 5 extratelencephalic neurons, including von Economo neurons, and identified selective depletion of specific layer 2/3 and layer 5 neuron subtypes, convergent across genotypes. Despite selective neuronal loss, disease-associated transcriptional changes were convergent across excitatory neuron populations, suggesting that they reflect upstream pathophysiology or shared responses to local neurodegeneration. By relating neighborhood-level depletion in disease to gene expression in controls, we found that baseline cellular respiration and ATP synthesis predict neuronal vulnerability in disease. These findings define molecular correlates of selective neuronal vulnerability in FTD and provide a framework linking cell type and state to neurodegeneration.
From Oceans to Orbit: Radiography at the Threshold of a New Human Environment
McMillan, Alan B. , Abbara, Suhny , McMillan, Alan B

Radiology | July 14, 2026 | Volume: 320 | Issue: 1 | Pages: No page available

10.1148/radiol.261976 | PMID 42446354 Get It

SpaceXray: Feasibility and Diagnostic Capabilities of On-Orbit Medical Radiography
Gifford, Sheyna E. , Pohlen, Michael , Wang, Adam S. , Lerner, David J. , Wadhwa, Anna , Cairnie, Michael, Walter, Jeanne, Karim, Karim S. , Tilley, Steven , Karnick, Amol , Rosenberg, Marissa A , Petersen, Lonnie G , Gifford, Sheyna E. , Pohlen, Michael , Lerner, David J. , Wadhwa, Anna , Cairnie, Michael, Walter, Jeanne, Karim, Karim S. , Tilley, Steven

Radiology | July 14, 2026 | Volume: 320 | Issue: 1 | Pages: No page available

10.1148/radiol.260258 | PMID 42446357 Get It

By acquiring the first human and equipment radiographs in space, this study demonstrated the feasibility of on-orbit radiography and expanded diagnostic capabilities for crew health and hardware evaluation.
Comparative Seizure Outcomes of Vagus Nerve Stimulation, Deep Brain Stimulation, and Their Combination in Lennox–Gastaut Syndrome
Kuo, Cheng‐Yen , Singh, Raunak, Sharma, Shelja, Nguyen, Ryan D. , Wong‐Kisiel, Lily C. , Starnes, Keith , Gregg, Nicholas M. , Gompel, Jamie Van, Miller, Kai J., Worrell, Gregory A. , Wong-Kisiel, Lily C. , Van Gompel, Jamie, Lundstrom, Brian Nils , Worrell, Gregory A , Gregg, Nicholas M , Singh, Raunak , Starnes, Donnie Keith , Kuo, Cheng‐Yen , Nguyen, Ryan Toan Dinh , Gompel, Jamie J. Van , Miller, Kai J. , Lundstrom, Brian N.

Annals of Neurology | July 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ana.78308 | PMID 42446202 Get It

Objective Lennox–Gastaut syndrome (LGS) is a severe treatment‐resistant epilepsy. Although vagus nerve stimulation (VNS) and deep brain stimulation (DBS) are established therapies, comparative data and the impact of dual neuromodulation remain limited. We compared seizure outcomes across VNS, DBS, and combined DBS + VNS therapy in LGS. Methods This retrospective cohort study at Mayo Clinic (2005–2024) included LGS patients treated with VNS and/or DBS . Seizure frequency was assessed at 6, 12, and 24 months post‐stimulation. Responder was defined as 50% or more seizure reduction. Results Forty patients were included (42% female, median, 150 seizures/month). Eleven patients underwent sequential VNS followed by DBS and contributed data to 2 treatment epochs, yielding 3 treatment groups: VNS alone (n = 29), DBS alone (n = 12), and DBS + VNS (n = 10). At 24 months, median seizure reduction rate was comparable between VNS (50%; 95% confidence interval [ CI], 44–75%) and the overall DBS cohort (59%, 95% CI, 33–86%) ( p = 0.54). However, a significant difference emerged when comparing the 3 treatment arms ( p = 0.027). Specifically, DBS + VNS therapy yielded significantly greater median reduction rate (81%, 95% CI, 60–99%) than DBS alone (43%, 95% CI, 0–58%) ( p adj = 0.027) or VNS alone (50%, 95% CI, 44.4–75.0%) ( p adj = 0.048). Four patients attained sustained seizure freedom above 1 year at last follow‐up. Interpretation VNS and DBS provide comparable seizure reduction in LGS over a 2‐year follow‐up period. DBS + VNS was associated with further improvements in seizure reduction in this small, retrospective dataset. This possibility warrants further investigation. ANN NEUROL 2026
Simultaneous Laparoscopic Femoral Hernia Repair and Retropubic Mid-Urethral Sling Placement in Female Patient with Stress Urinary Incontinence and Symptomatic Femoral Hernia
Hurd, Kessler , Chebel, Roy, Stewart, Kelley, Heisler, Christine A. , Rendell, Victoria R., Heisler, Christine A. , Chebel, Roy , Rendell, Victoria R.

Videoscopy™ | July 14, 2026 | Volume: 35 | Issue: 1 | Pages: No page available

10.1177/23733063261465493 Get It

Positive Strongyloides Serology: A Descriptive Analysis Across Geographically Distinct Academic Medical Centers
Nagarakanti, Sandhya R., Shubeilat, Jamilah L., Abdulsahib, Ali, Dyal, Natasha P., Biondi, Matt, Hentz, Joseph, Kaleta, Erin, Nagarakanti, Sandhya , Nagarakanti, Sandhya Rani , Vikram, Holenarasipur R. , Shubeilat, Jamilah , Abdulsahib, Ali, Dyal, Natasha Priya , Biondi, Matt V., Kaleta, Erin

Transplant Infectious Disease | July 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/tid.70276 | PMID 42446036 Get It

ABSTRACT Background Strongyloides stercoralis is an intestinal parasitic nematode that can infect humans with a 2%–7% prevalence in the United States. Immunosuppression is a crucial risk factor for disseminated infection. Diagnosis is often delayed and targeted treatment is frequently initiated late. We therefore sought to review the prevalence of positive Strongyloides antibody results and undertook a descriptive analysis of such patients. Methods We retrospectively reviewed patients with positive Strongyloides IgG serology from August 2012 to April 2023 across geographically distinct academic medical centers. Study period pre‐dated universal donor and recipient Strongyloides screening recommendation by the Organ Procurement and transplantation network (OPTN). Clinical presentation was classified into three categories: chronic infection (positive Strongyloides IgG serology without additional clinical manifestations), hyperinfection syndrome (positive serology with involvement of the skin, gastrointestinal tract, or lungs), and disseminated infection (positive serology with involvement beyond those typically involved in hyperinfection). Results A total of 412 patients were identified; median age was 59 years and 66% (272) were male. The primary indication for testing was pretransplant evaluation in 230 (56%), eosinophilia workup in 84 (20%), suspicion of symptomatic infection in 74 (18%), testing based on travel history in 27 (7%), and pre‐immunosuppression screening in 27 (7%). Furthermore, 401 patients (97.3%) were categorized as having chronic infection, 10 patients (2.42%) had hyperinfection, and one patient (0.24%) had disseminated infection, presenting with Escherichia coli bacteremia and meningitis. Symptomatic infection was more common at the Mayo Clinic in Rochester and Mayo Clinic Health Sciences than at the Arizona and Florida Mayo Clinic sites (6% vs. 2%, p = 0.079). Treatment was administered to 366/412 (89%) patients. Conclusion Most patients with positive Strongyloides serology were asymptomatic, and treatment regimens were not uniform. Patients who tested positive should be treated prior to immunosuppression initiation, though this was not systematically assessed in this cohort. The observed variability in treatment regimens highlights the need for standardized protocols.
Digital biomarkers in cardiovascular medicine: a scientific statement of the ESC Working Group on e-Cardiology, the ESC Working Group on Cardiovascular Pharmacotherapy, the European Heart Rhythm Association (EHRA) of the ESC, the Association for Acute Card
Corredoira, Pablo Manuel Fernández, Kaski, Juan Carlos, Duncker, David , Tubaro, Marco , Schuuring, Mark J. , Mamas, Mamas, Petersen, Steffen E, Kemps, Hareld M C, Locati, Emanuela T, Hill, Loreena, Keser, Nurgül , Verstrael, Axel , Friedman, P A, Casado-Arroyo, Rubén , Corredoira, Pablo M , Dörr, Marcus , Wilhelm, Matthias , Schuuring, Mark J , Mueller, Christian , Dilaveris, Polychronis E , Casado-Arroyo, Rubén , Duncker, David , Kaski, Juan Carlos , Wilhelm, Matthias , Petersen, Steffen E. , Vidal-Pérez, Rafael , Jensen, Magnus Thorsten , LUCIA, RAFFAELE DE , Hill, Loreena , Ramírez, Julia , Cluitmans, Matthijs J M , Friedman, Paul A.

European Heart Journal - Digital Health | July 14, 2026 | Volume: 7 | Issue: 6 | Pages: No page available

10.1093/ehjdh/ztag074 | PMID 42491935 Get It

Abstract Cardiovascular disease is the leading cause of morbidity and mortality globally, imposing a substantial patient burden. Digital biomarkers derived from digital health technologies enable quantifiable, near-continuous, real-world capture of pathophysiological signals and are increasingly used across cardiovascular medicine. Their growth is often supported by big data analytics, artificial intelligence and connected sensors within the Internet of Things. This scientific statement systematically reviews digital biomarkers, their clinical utility across the cardiovascular care continuum, and summarizes major methodological and implementation challenges. We searched PubMed/MEDLINE, Embase and Scopus for phase III–IV cardiovascular trials published between 1 January 2019 and 1 August 2024 that collected digital biomarkers. We identified 541 records and included 32 trials (40 reports) enrolling 32 246 participants (44.71% women; mean age 66.2 ± 11.0 years). Heart failure was the most frequent target condition (16 trials, 50%), followed by cardiac implantable electronic devices trials (12 trials, 38%). Digital biomarkers included cardiac rhythm and heart rate, blood pressure, body weight, impedance-based measures, haemodynamic pressures, and physical activity and sleep patterns captured using diverse sensor technologies. Methodological quality was good (modal quality score 5; range 3–7), although most trials were unblinded. Current studies suggest potential clinical utility in selected cardiovascular conditions. Implementation remains challenging because of measurement variability, privacy and regulatory requirements, affordability and reimbursement barriers and inequities in access. Robust validation and outcome- and cost-effectiveness evidence are still needed. Registration number: CRD42024573879.
International Expert Consensus on the Diagnosis and Clinical Management of Primary Fetal Pleural Effusion
Abiad, May , Javinani, Ali, Lopez, Maria C., Mossayebi, Matthew H., Mieghem, Tim Van, Russo, Francesca, Ruano, Rodrigo , Britto, I.S. , Miller, Russell, Yinon, Yoav, Cincotta, Robert, Perrone, Erin E. , Sago, Haruhiko , Haak, Monique C., Sans, Mar Bennasar, Gonzalez, Gerardo Sepulveda, Chmait, Ramen H., Habli, Mounira, Sun, Raphael C., Chaveeva, Petya, Espinoza, Jimmy, Schenone, Mauro , Sun, Lu‐Ming, Nassr, Ahmed A., Moon‐Grady, Anita, Shamshirsaz, Alireza A., Krispin, Eyal, Araujo Júnior, Edward , Britto, Ingrid Schwach Werneck , Perrone, Erin E , Sago, Haruhiko , Khalil, Asma , Meller, Cesar , Mustafa, Hiba J , Schenone, Mauro H , Papanna, Ramesha , Ruano, Rodrigo , Abiad, May , Javinani, Ali , Mossayebi, Matthew H. , Van Mieghem, Tim , Russo, Francesca Maria , Miller, Russell , Yinon, Yoav , Cincotta, Robert , Haak, Monique C. , Sans, Maria del Mar Bennasar, Gonzalez, G. Sepulveda, Chmait, Ramen H. , Habli, Mounira A. , Chaveeva, Petya , Espinoza, Jimmy , Nassr, Ahmed A. , Moon‐Grady, Anita J. , Shamshirsaz, Alireza A. , Krispin, Eyal

Prenatal Diagnosis | July 14, 2026 | Volume: 46 | Issue: 9 | Pages: 1312-1322

10.1002/pd.70221 | PMID 42444393 Get It

ABSTRACT Objective(s) Fetal pleural effusion is a rare condition that may significantly impact fetal and neonatal outcomes. Currently, no universal standardized approach exists for diagnosing and managing primary fetal pleural effusions. This study aimed to develop structured, expert‐based clinical guidelines for the diagnosis, monitoring, management, and follow‐up care of primary fetal pleural effusion. Methods A Delphi method was employed to achieve consensus among an international panel of experts in fetal medicine. Experts were selected based on their clinical expertise, affiliations, and relevant publications. A three‐round anonymous electronic survey was sent to the full panel. In the initial two rounds, participants rated each statement on a Likert scale (1–5) and provided suggestions for modifications. Statements with a median score of five and no suggested changes were accepted as consensus. Statements with a median score below four were rejected. Statements scoring a median of four were revised according to suggestions and reconsidered in the subsequent round. In the final round, participants indicated their agreement or disagreement with the remaining statements. Consensus was defined as agreement from more than 70% of participants with no suggestions for further changes. Results A total of 101 expert clinicians accepted the invitation and completed the first round with 73 (72%) completing all three rounds. Consensus statements were achieved on aspects of diagnosis, monitoring, intervention, post‐intervention management, and delivery. Key recommendations concerning the diagnosis of primary fetal pleural effusion include the use of ultrasound as the primary modality for identifying fetal pleural effusion and excluding secondary causes through detailed genetic, infectious, and metabolic evaluations. Management strategies emphasized thoracoamniotic shunting as the preferred intervention in hydropic fetuses with primary pleural effusion. Experts reached consensus that shunt placement could be offered as early as 16 weeks. No consensus was reached for isolated effusion without hydrops, as management was considered case‐dependent. The importance of ultrasonographic monitoring of fetal status at least weekly post‐intervention was strongly endorsed. Conclusion(s) The Delphi method facilitated the development of a consensus‐based protocol for diagnosing and managing primary fetal pleural effusion. These standardized guidelines are intended to enhance clinical practice across various settings, improve perinatal outcomes, and serve as a foundation for future research for this high‐risk fetal condition.
Clinical Recommendations for Remote Robotic Assisted Surgery From the CRSA 2025 International Consensus Conference
Raptis, Dimitri Aristotle , Kavoussi, Louis, Wren, Sherry M. , Fowler, Dennis, Anvari, Mehran, Bianco, Francesco, Liang, Xiao, Li, Zheyong, Yin, Xiaoyu, Piccoli, Micaela, Marks, John, Shen, Baiyong, Ko, Clifford, Seeliger, Barbara, Hagendoorn, Jeroen, Essani, Rahila, Walsh, R. Matthew, Oleynikov, Dmitry, Jones, Stephanie B., Bindal, Vivek , Kim, Hyun Koo, Hyung, Woo Jin, Hashimoto, Daniel, Chen, Liaohai Leo, Burt, Bryan M., Lafaro, Kelly, Elli, Fernando, Wilson, Erik, Bianchi, Paolo Pietro, Morgan, Annette, Bartlett, Stephen T., Rashidi, Laila, Yu, Liu, Gawkins, Bill, Hinoul, Piet, Peine, Bill, Woo, Yanghee, Raoof, Mustafa, Jones, Daniel, Deshpande, Supriya, Bernard, Jordana , Wang, Yulun, Broering, Dieter C., Giulianotti, Pier Cristoforo, Fong, Yuman , Raptis, Dimitri , Wren, Sherry M , Aldousari, Saad , Ruurda, Jelle P. H. , Bindal, Vivek , Melstrom, Laleh , Celotto, Francesco , Kudsi, Yusef , Ratti, Francesca , Bernard, Jordana , Kavoussi, Louis R., Fowler, Dennis L. , Anvari, Mehran , Bianco, Francesco Maria , Piccoli, Micaela , Marks, John, Ko, Clifford, Seeliger, Barbara , Hagendoorn, Jeroen , Essani, Rahila, Walsh, R. Matthew , Oleynikov, Dmitry , Hyung, Woo Jin , Hashimoto, Daniel A. , Burt, Bryan M. , Lafaro, Kelly J. , Elli, Fernando, Bianchi, Paolo Pietro, Rashidi, Laila, Hinoul, Piet , Peine, Bill, Woo, Yanghee , Raoof, Mustafa , Jones, Daniel, Deshpande, Supriya , Bröering, Dieter C. , Giulianotti, Pier Cristoforo

World Journal of Surgery | July 14, 2026 | Volume: 50 | Issue: 8 | Pages: 2274-2288

10.1002/wjs.70468 | PMID 42444290 Get It

ABSTRACT Background Implementation of remote robotic‐assisted surgery (rRAS) has the potential to significantly improve access to high‐quality surgical care for patients worldwide. Advances in robotic systems and telecommunications now enable highly reliable, low latency, and cybersecure connectivity. These technological developments, together with the broader adoption of telemedicine, have driven an increasing interest in the implementation of rRAS. Methods The Clinical Robotic Surgery Association (CRSA) convened a conference to develop international clinical recommendations for rRAS using the Danish Model of Consensus. The society identified five key issue categories and invited a panel of experts to address specific questions for each. Panel members and a jury of 10 unbiased, non‐expert in rRAS professionals participated in a day‐long conference on November 19, 2025 (Los Angeles, USA). During the conference, participants presented, discussed, and reached consensus on specific guidelines relevant to each category. Immediately after the conference, the jury reviewed and approved the recommended guidelines. Results Multiple recommendations were approved for each of the following categories: Operating Models, Roles and Responsibilities (2 recommendations), Clinical Pathway (2 recommendations), Emergency Management (8 recommendations), Technical Considerations (5 recommendations), and Medico‐legal and Ethical Considerations (4 recommendations). Conclusions There was consensus that with recent advances in telecommunication and robotic technologies, rRAS can be offered safely and effectively if the identified safeguards are realized. Adoption of rRAS is expected to continue advancing rapidly.
In memoriam: Amir Lerman 1956–2026
Glikson, Michael , Rihal, Charanjit S. , Gersh, Bernard J. , Gersh, Bernard J , Glikson, Michael , Rihal, Charanjit S.

European Heart Journal | July 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/eurheartj/ehag433 Get It